𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term safety and efficacy of deferasirox (Exjade®) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease

✍ Scribed by Elliott Vichinsky; Françoise Bernaudin; Gian Luca Forni; Renee Gardner; Kathryn Hassell; Matthew M. Heeney; Baba Inusa; Abdullah Kutlar; Peter Lane; Liesl Mathias; John Porter; Cameron Tebbi; Felicia Wilson; Louis Griffel; Wei Deng; Vanessa Giannone; Thomas Coates


Book ID
108677301
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
305 KB
Volume
154
Category
Article
ISSN
0007-1048

No coin nor oath required. For personal study only.